COST EFFECTIVENESS OF USING TERLIPRESSIN TO TREAT HEPATORENAL SYNDROME.
Luciana Marcondes FerreiraDébora Raquel Benedita TerrabuioCaroline Marcondes FerreiraDaniel Ferraz de Campos MazoLuciana Bertocco de Paiva HaddadPublished in: Arquivos de gastroenterologia (2022)
A cost-effectiveness analysis showed that terlipressin in combination with albumin when administered concomitantly to patients who were diagnosed with type 1 HRS is cost-effective compared to norepinephrine in combination with albumin administered in a controlled environment.
Keyphrases